RxDoctor Payments Data

John Bruner

Obstetrics & Gynecology · Somerset, KYNPI 1194821249

Payments from drug & device makers

What this record shows

This record is dominated by education: $74,086 of the $81,505 with a category attached, or 90.9%. Intuitive Surgical accounts for 98.6% of it on its own, with 20 other manufacturers making up the rest. Among obstetrics & gynecology clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$81,505in general payments, 2019–2025

Across 134 payments — averaging $608.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$80K
  • Shield Therapeutics Inc$247
  • AbbVie$128
  • Astellas Pharma US Inc$116
  • Organon$113
  • Pfizer$71
  • plus $455 from 15 others

What the payments were for

  • Travel & lodging$2,4413%
  • Food & beverage$4,9776%
  • Education$74,08691%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$81,505 in reported general payments places this provider in the 95th percentile of 474 obstetrics & gynecology providers in Kentucky.

See all obstetrics & gynecology providers in Kentucky

Medicare billing

Part B allowed, 2024
$15,377
Medicare patients
84
Services billed
160

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron19$12,117
Estradiol74$2,049
Estradiol (Twice Weekly)Estradiol11$670
ValacyclovirValacyclovir Hcl23$275
Tolterodine Tartrate ErTolterodine Tartrate12$220
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst11$147
Ibuprofen23$91
Hydrocortisone11$79
Oxycodone Hcl14$48
Medroxyprogesterone Acetate11$41
Promethazine Hcl20$38

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$28$12,11719 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 474 obstetrics & gynecology providers in Kentucky.

Other obstetrics & gynecology in Somerset

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →